Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications.
10.1007/s13534-017-0016-5
- Author:
Hohyeon LEE
1
;
Haemin KIM
;
Hyounkoo HAN
;
Minji LEE
;
Sunho LEE
;
Hongkeun YOO
;
Jin Ho CHANG
;
Hyuncheol KIM
Author Information
1. Department of Chemical and Biomolecular Engineering, Sogang University, 35 Baekbeom-ro, Mapo-gu, Seoul 04107, Republic of Korea. hyuncheol@sogang.ac.kr
- Publication Type:Review
- Keywords:
Microbubble;
Ultrasound;
Contrast agent;
Theragnostics;
Sonoporation
- MeSH:
Arthritis, Rheumatoid;
Blood Vessels;
Breast;
Cardiovascular System;
Contrast Media;
Inflammation;
Joints;
Microbubbles*;
Nanomedicine;
Nitrogen;
Osteoarthritis;
Polymers;
Stomach;
Thyroid Neoplasms;
Ultrasonography*
- From:
Biomedical Engineering Letters
2017;7(2):59-69
- CountryRepublic of Korea
- Language:English
-
Abstract:
Ultrasound was developed several decades ago as a useful imaging modality, and it became the second most popular diagnostic tool due to its non-invasiveness, real-time capabilities, and safety. Additionally, ultrasound has been used as a therapeutic tool with several therapeutic agents and in nanomedicine. Ultrasound imaging is often used to diagnose many types of cancers, including breast, stomach, and thyroid cancers. In addition, ultrasound-mediated therapy is used in cases of joint inflammation, rheumatoid arthritis, and osteoarthritis. Microbubbles, when used as ultrasound contrast agents, can act as echo-enhancers and therapeutic agents, and they can play an essential role in ultrasound imaging and ultrasound-mediated therapy. Recently, various types of ultrasound contrast agents made of lipid, polymer, and protein shells have been used. Air, nitrogen, and perfluorocarbon are usually included in the core of the microbubbles to enhance ultrasound imaging, and therapeutic drugs are conjugated and loaded onto the surface or into the core of the microbubbles, depending on the purpose and properties of the substance. Many research groups have utilized ultrasound contrast agents to enhance the imaging signal in blood vessels or tissues and to overcome the blood–brain barrier or blood-retina barrier. These agents are also used to help treat diseases in various regions or systems of the body, such as the cardiovascular system, or as a cancer treatment. In addition, with the introduction of targeted moiety and multiple functional groups, ultrasound contrast agents are expected to have a potential future in ultrasound imaging and therapy. In this paper, we briefly review the principles of ultrasound and introduce the underlying theory, applications, limitations, and future perspectives of ultrasound contrast agents.
